AvantGuard News

We are thrilled to announce that AvantGuard has been recognized as a key player in the global Surface Disinfectants market by IMIR Market Research Pvt. Ltd. , a leading global market research and consulting company. According to the latest report, the Surface Disinfectants market is projected to reach USD 6,422.42 Million by 2028, with a remarkable 5.3% Compound Annual Growth Rate (CAGR). This recognition is a testament to AvantGuard's commitment to innovation and excellence

In the bustling landscape of innovation, AvantGuard emerged as a beacon of groundbreaking technology at this year's TechCrunch Disrupt 2023 . Handpicked from thousands of contenders, we proudly stood among the 200 startups showcased at the esteemed Startup Battlefield. This annual event is renowned for unveiling revolutionary startups and discussing the forefront of tech innovation. AvantGuard's journey was nothing short of remarkable. At the heart of our presentation was Ava

Image Credits: Christine Hall, TechCrunch / AvantGuard CEO, Edward “Ted” Eveleth AvantGuard's journey at TechCrunch Disrupt 2023 was nothing short of amazing! Ted Eveleth, AvantGuard's CEO, showcased the groundbreaking antimicrobial technology, which turns chlorine into the ultimate surface protectant. Covered in TechCrunch's article is exactly what AvantGuard is doing differently than your average chlorine-based disinfectant. Beyond surfaces, this innovative polymer has a w

Image courtesy of the National Institute of Allergy and Infectious Diseases Nosocomial infections, commonly know as healthcare associated infections (HAIs) strike 1 in 31 hospital patients daily, but we can fight back! AvantGuard’s Ted Eveleth breaks it down in his latest article on Medical Design & Outsourcing. The article takes an in depth look at: The challenges and importance of preventing infections linked to medical devices in healthcare settings The role of antimicrobi

We are excited to announce that AvantGuard has been handpicked to exhibit at TechCrunch Disrupt 2023, earning a coveted spot in the...

AvantGuard has been awarded a $325K NIH Phase I Grant for non-coating antimicrobial, anti-host deposition, anti-inflammatory urinary catheters. Catheter-associated urinary tract infection (CAUTI) is the most common type of healthcare-associated infection, however currently there is no effective technology to address the problem. Antimicrobial (anti-biofilm) functionality on the catheter surface is an important field that has gained a lot of attention; however, commercial app

Working Smart and Working Hard AvantGuardTM is creating innovative solutions that manage surfaces and provide long-term protection against viruses, bacteria, and fungi/ mould, in a variety of applications. The company’s proprietary combinations of specialty molecules and polymers are customized to provide prolonged antimicrobial efficacy to a wide range of surfaces and materials. Here’s a little more about the company and its CEO, Ted Eveleth as he is crowned Most Influential

NEW YORK, May 11, 2023 /PRNewswire/ -- AvantGuard, a fast-growing company in the antimicrobial industry, announced today the successful...

AvantGuard, Inc. is pleased to announce a $1 million Phase III award from the United States Department of Agriculture (USDA) to demonstrate the continuing antimicrobial benefit of AvantGuard247™ in real world food processing environment and identify the gaps for adopting AvantGuard247™ in the food safety market. This award will allow AvantGuard to demonstrate the broad-spectrum antimicrobial function of AvantGuard247™ against poultry/meat related pathogens as well as perform

AvantGuard, Inc. is pleased to announce a $1.7 million Phase II SBIR award from the National Institutes of Health (NIH) to continue...

Are you concerned about Norovirus (commonly known as the stomach bug) and its potential impact on your health? Look no further! Below,...

Are you aware of the surprising role that environmental factors play in infection transmission? We invite you to read AvantGuard's latest...

ITHACA, N.Y., March 23, 2023 / PRNewswire / -- AvantGuard, announced today the unveiling of its new brand identity as a transformative "specialty chemical company" using groundbreaking antimicrobial chemistry of the N-halamine molecule to solve major disinfection and pathogen problems in the world today. The company's proprietary combination of specialty molecules offers the potential to create multiple, novel products, additives, and disinfecting methods to transform the way